BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISCA
2526
DELISTED
International Speedway Corp
ISCA
| $244K | ﹤0.01% |
5,429
+1,195
| +28% | +$53.9K |
|
|
ALDR
2527
DELISTED
Alder Biopharmaceuticals
ALDR
| $244K | ﹤0.01% |
12,943
+5,017
| +63% | +$57.4K |
|
2528
ICF International
ICFI
$1.6B
| $244K | ﹤0.01% |
2,886
-67
| -2% | -$5.44K |
|
|
VGR
2529
DELISTED
Vector Group Ltd.
VGR
| $243K | ﹤0.01% |
28,720
+1,433
| +5% | +$11K |
|
2530
Clearway Energy Class C
CWEN
$7.06B
| $242K | ﹤0.01% |
13,234
-1,841
| -12% | -$32.6K |
|
|
TERP
2531
DELISTED
TerraForm Power, Inc
TERP
| $241K | ﹤0.01% |
13,246
+964
| +8% | +$15.6K |
|
|
UHT
2532
Universal Health Realty Income Trust
UHT
$573M
| $241K | ﹤0.01% |
2,342
+680
| +41% | +$64K |
|
|
BHVN
2533
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $241K | ﹤0.01% |
5,769
+2,294
| +66% | +$96.9K |
|
2534
Gibraltar Industries
ROCK
$1.46B
| $241K | ﹤0.01% |
5,239
-881
| -14% | -$36.9K |
|
2535
Heron Therapeutics
HRTX
$63.5M
| $240K | ﹤0.01% |
12,959
+3,490
| +37% | +$64.2K |
|
|
AQUA
2536
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $239K | ﹤0.01% |
14,063
+1,596
| +13% | +$24K |
|
2537
JELD-WEN Holding
JELD
$164M
| $238K | ﹤0.01% |
12,313
+3,317
| +37% | +$64.1K |
|
2538
Enerpac Tool Group
EPAC
$1.91B
| $237K | ﹤0.01% |
10,823
-1,042
| -9% | -$23.8K |
|
2539
BCE
BCE
$21.6B
| $237K | ﹤0.01% |
4,900
| – | – |
|
2540
Park National Corp
PRK
$3.72B
| $237K | ﹤0.01% |
2,500
-339
| -12% | -$32K |
|
2541
Ironwood Pharmaceuticals
IRWD
$714M
| $237K | ﹤0.01% |
27,602
+8,676
| +46% | +$84.3K |
|
|
FBC
2542
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $236K | ﹤0.01% |
6,327
-91
| -1% | -$3.2K |
|
2543
AMERISAFE
AMSF
$504M
| $236K | ﹤0.01% |
3,574
-429
| -11% | -$28.4K |
|
2544
DNOW Inc
DNOW
$3.04B
| $236K | ﹤0.01% |
20,562
+1,402
| +7% | +$17.3K |
|
2545
First Commonwealth Financial
FCF
$2.18B
| $236K | ﹤0.01% |
17,742
+4,618
| +35% | +$59.9K |
|
|
POLY
2546
DELISTED
Plantronics, Inc.
POLY
| $235K | ﹤0.01% |
6,302
+2,765
| +78% | +$94K |
|
|
FSCT
2547
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $235K | ﹤0.01% |
6,190
+2,497
| +68% | +$91.2K |
|
2548
eHealth
EHTH
$39.7M
| $234K | ﹤0.01% |
3,508
+753
| +27% | +$67.9K |
|
2549
Santander
BSBR
$43.1B
| $234K | ﹤0.01% |
22,435
+9,394
| +72% | +$100K |
|
2550
PUT
Nabors Industries
NBR
$1.33B
| $233K | ﹤0.01% |
25
-3
| -11% | -$337 |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.